PANKAJ MOHAN, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sonnet BioTherapeutics Holdings, Inc.

Filing Date Source Excerpt
2021-05-25 Dr. Mohan received a Ph.D. in Biochemical Engineering from the School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom, a masters in Financial Management from Middlesex University Business School, London, United Kingdom, an Executive Management Program (AMP) from Fuqua School of Business at Duke University and a Bachelor of Chemical Engineering from the Indian Institute of Technology in Roorkee, India.
2022-04-12 Dr. Mohan received a Ph.D. in Biochemical Engineering from the School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom... The Company believes Dr. Mohan is capable of making valuable contributions to the Board due to his extensive knowledge of the biopharmaceutical industry and his prior experience as an executive officer.
2022-08-25 PANKAJ MOHAN, PH.D. Chief Executive Officer and Chairman of the Board
2023-08-07 Dr. Mohan received a Ph.D. in Biochemical Engineering from the School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom.
2024-08-19 Dr. Mohan received a Ph.D. in Biochemical Engineering from the School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom.

Data sourced from SEC filings. Last updated: 2026-02-03